MENU
LYRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lyra Therapeutics (LYRA) Ownership - Who owns Lyra Therapeutics?
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases... Show more
Profile
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.31M
P/E Ratio
N/A
Total Cash
40.58M
Projected Growth
N/A
Total Debt
34.38M
Revenue
1.53M
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
0.62
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
LYRA
Capitalization
7.31M
P/E Ratio
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash
40.6M
Total Cash/Share
0.62
Total Debt
34.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
1.53M
ROE
N/A
Book Value
11.6M
P/B Ratio
0.66
Cash Flow
N/A
Earnings
-1.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
65K
Current Ratio
3.41
Current Revenue Per Employee
2402.30
Dividends Per Share - Security
N/A
EBITDA
-60.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-89.43
Shares Held By Institutions
6.9M
Shares Outstanding - Current
65.9M
Total Liabilities
54.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-46.172
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com